Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer
Chemoradiation is associated with improved OS in high-risk EC patients regardless of various factors. This data suggests chemoradiation as a preferred treatment option, however, prospective trials directly comparing chemotherapy, radiation, and chemoradiation are needed for confirmation.
Authors
- Runjia Li (ORCID: https://orcid.org/0000-0002-6827-1144)
- Alison Garrett (ORCID: https://orcid.org/0000-0001-5185-7862)
- G.K. Balasubramani (ORCID: https://orcid.org/0000-0001-7221-1825)
- Jamie Lesnock
- Megan Lander (ORCID: https://orcid.org/0000-0003-2405-2537)
- Paniti Sukumvanich (ORCID: https://orcid.org/0000-0001-5555-8667)
- Shannon Rush (ORCID: https://orcid.org/0000-0003-2310-7137)
- John A. Vargo (ORCID: https://orcid.org/0000-0002-3260-3151)
- Ron Buckanovich
Institutions
- University of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.gore.2025.101756
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00